Our analysis revealed the signatures of Endblood1 and CAF1 were also related to poor prognosis in NPC, and there existed less Endblood1 and CAF1 cells in group III, which had longer progress-free survival rates. This evidence concerns the gene CNOT8 and nasopharyngeal carcinoma.